Mostafa, S A <br/><br/>
Modelling incremental benefits on complications rates when targeting lower HbA  [electronic resource] 

 -  Diabetic medicine : a journal of the British Diabetic Association  01 2018 
 - 72-77 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1464-5491 
<br/><br/><label>Standard No.: </label>10.1111/dme.13533  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Amputation, Surgical--statistics & numerical data<br/>Blindness--epidemiology<br/>Cardiovascular Diseases--complications<br/>Diabetes Complications--epidemiology<br/>Diabetes Mellitus, Type 2--complications<br/>Diabetic Foot--epidemiology<br/>Diabetic Retinopathy--epidemiology<br/>Female<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Male<br/>Middle Aged<br/>Models, Statistical<br/>Myocardial Infarction--epidemiology<br/>Patient Care Planning<br/>Stroke--epidemiology